Upregulation of miR-598 promotes cell proliferation and cell cycle progression in human colorectal carcinoma by suppressing INPP5E expression

被引:18
|
作者
Li, Kun-Ping [1 ]
Fang, Yong-Ping [1 ]
Liao, Jin-Qi [1 ]
Duan, Jin-Dong [1 ]
Feng, Li-Guang [1 ]
Luo, Xiao-Zai [1 ]
Liang, Zhi-Jian [1 ]
机构
[1] Huizhou First Hosp, Dept Gen Surg, 20 San Xin Nan Rd, Huizhou 516000, Guangdong, Peoples R China
关键词
miR-598; colorectal cancer; 72 kDa inositol polyphosphate-5-phosphatase; cell proliferation; cell cycle; CANCER CELLS; METASTASIS; INVASION;
D O I
10.3892/mmr.2017.8207
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer (CRC) is one of the most common types of cancer worldwide. Recently, microRNAs (miRs) have been considered as novel therapeutic targets for the treatment of cancer. miR-598 is a poorly investigated miR. The underlying mechanism of miR-598 in CRC cells remains to be elucidated. In the present study, miR-598 was demonstrated to be significantly upregulated in CRC tissue by analyzing data from The Cancer Genome Atlas and the Gene Expression Omnibus. The results of a polymerase chain reaction demonstrated that miR-598 expression was significantly upregulated in CRC tissues and cells. Gain of function and loss of function assays demonstrated that miR-598 significantly promoted cell proliferation and cell cycle progression. miR-598 was demonstrated to modulate cell functions by regulating 72 kDa inositol polyphosphate-5-phosphatase (INPP5E). In addition, knockdown of INPP5E counteracted the growth arrest caused by an miR-598-inhibitor. In conclusion, the present study demonstrated that miR-598 contributed to cell proliferation and cell cycle progression in CRC by targeting INPP5E.
引用
收藏
页码:2991 / 2997
页数:7
相关论文
共 50 条
  • [31] miR-362-5p promotes cell proliferation and cell cycle progression by targeting GAS7 in acute myeloid leukemia
    Wu, Fuqun
    Yin, Changxin
    Qi, Junhua
    Duan, Deyu
    Jiang, Xi
    Yu, Jianhua
    Luo, Zhaofan
    HUMAN CELL, 2020, 33 (02) : 405 - 415
  • [32] miR-362-5p promotes cell proliferation and cell cycle progression by targeting GAS7 in acute myeloid leukemia
    Fuqun Wu
    Changxin Yin
    Junhua Qi
    Deyu Duan
    Xi Jiang
    Jianhua Yu
    Zhaofan Luo
    Human Cell, 2020, 33 : 405 - 415
  • [33] miR-488-5p promotes esophageal squamous cell carcinoma progression by suppressing the P53 pathway
    Su, Chang
    Liu, Wenxiu
    Jiang, Tao
    Liu, Junfeng
    JOURNAL OF THORACIC DISEASE, 2021, 13 (09) : 5534 - 5545
  • [34] MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression
    Zhang, Kejin
    Guo, Ling
    GENE, 2018, 641 : 272 - 278
  • [35] LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384
    Chen, Zili
    Yu, Chao
    Zhan, Lei
    Pan, Yaozhen
    Chen, Ling
    Sun, Chengyi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (10): : 2299 - 2309
  • [36] MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2
    Ma, Qiang
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2019, 24
  • [37] MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2
    Qiang Ma
    Cellular & Molecular Biology Letters, 2019, 24
  • [38] MYCN-induced E2F5 promotes neuroblastoma cell proliferation through regulating cell cycle progression
    Liu, Ying
    Liu, Donghai
    Wan, Wuqing
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 511 (01) : 35 - 40
  • [39] Loss of BAX by miR-365 Promotes Cutaneous Squamous Cell Carcinoma Progression by Suppressing Apoptosis
    Zhou, Liang
    Gao, Ruirui
    Wang, Yinghui
    Zhou, Meijuan
    Ding, Zhenhua
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (06)
  • [40] Correction to: IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma
    Le Zhang
    Rong Lian
    Jingjing Zhao
    Xianming Feng
    Runyi Ye
    Lingxiao Pan
    Jueheng Wu
    Mengfeng Li
    Yongbo Huang
    Junchao Cai
    Cell & Bioscience, 9